ANALYSIS OF NON-SURGICAL COMPLICATIONS IN PATIENTS WITH IMPLANTED MECHANICAL SUPPORT DEVICES FOR THE LEFT VENTRICLE
DOI:
https://doi.org/10.31379/2411.2616.13.1.6Keywords:
left ventricle assist device (LVAD), anticoagulant target therapy (ATT), infection, nephrotic, pulmonary, aortic, right ventricle complicationsAbstract
The work was performed within the framework of a bilateral agreement on scientific cooperation between the NMAPE named P.L. Shupyk (Department of Anesthesiology & Intensive Care) and the Silesian Center for Heart Disease (Poland). Resume. The work is devoted to the study of infectious, nephrotic, neurological, pulmonary aortic, right ventricle and other complications in the early postoperative period in ten patients with implanted left ventricle assist devices (LVAD). The most common non-surgical complications include infections, ischemic-hemorrhagic lesions of the brain that arise in the postoperative period of acute renal failure. Conducting optimal antithrombotic therapy in such patients is an important method of treatment, especially in the early postoperative period. Most of the infectious complications develop in the exit places of the power cable of the implanted devices. An individual approach to preventive strategies is critical to improving patient outcomes. This article presents an analysis of complications that developed in the early postoperative period in ten patients with LVAD implanted devices in the Silesian Center for Heart Disease (SCCS), Poland. Patients were divided into two groups in the control group receiving classical anticoagulant targeted therapy (ATT), which included heparin, varfarin and aspirin and the subjects receiving an alternative ATT, that consisted of cropidogrel, thrombin inhibitors in combination with classical anticoagulant target therapy.
References
Morbidity and mortality in heart transplant candidates supported with mechanical circulatory support: is reappraisal of the current. / O. Wever-Pinzon [et al.] // Circulation. – 2013. – Vol. 127(4). – P. 452-62.
Hospital Readmissions After Continuous-Flow Left Ventricular Assist Device Implantation: Incidence, Causes, and Cost Analysis. / S.A. Akhter [et al.] // Ann Thorac Surg. – 2015. – Vol. 100(3). – P. 884-9.
HeartWare Bridge to Transplant ADVANCE Trial Investigators. HeartWare ventricular assist system for bridge to transplant: combined results of the bridge to transplant and continued access protocol trial. / M.S. Slaughter [et al.] // J Heart Lung Transplant. – 2013. – Vol. 32(7). – P. 675-83.
Adverse events in contemporary continuous-flow left ventricular assist devices: A multiinstitutional comparison shows significant differences. / J.M. Stulak [et al.] // J Thorac Cardiovasc Surg. – 2016. – Vol. 151(1). – P. 177-89.
Stroke After Left Ventricular Assist Device Implantation: Outcomes in the Continuous-Flow Era. / L. Harvey [et al.] // Ann Thorac Surg. – 2015. – Vol. 100(2). – P. 535-41.
Stroke while on long-term left ventricular assist device support: incidence, outcome, and predictors. / J.A. Morgan [et al.] // ASAIO J. – 2014. – Vol. 60(3). – P. 284-289.
Preoperative atrial fibrillation may not increase thromboembolic events in left ventricular assist device recipients on midterm follow-up. / Y. Xia [et al.] // J Heart Lung Transplant. – 2016. – Vol. 35(7). – P. 906-912.
HVAD Bridge to Transplant ADVANCE Trial Investigators. An analysis of pump thrombus events in patients in the HeartWare ADVANCE bridge to transplant and continued access protocol trial. / S.S. Najjar [et al.] // J Heart Lung Transplant. – 2014. – Vol. 33(1). – P. 23-34.
Development of a novel echocardiography ramp test for speed optimization and diagnosis of device thrombosis in continuous-flow left ventricular assist devices: the Columbia ramp study. / N. Uriel [et al.] // J Am Coll Cardiol. – 2012. – Vol. 60(18). – P. 1764-1775.
Prevention of HeartMate II Pump Thrombosis Through Clinical Management (PREVENT). / S. Maltais [et al.] // J Heart Lung Transplant. – 2016. – Vol. 35(4). – P. S161-S162.
Unexpected abrupt increase in left ventricular assist device thrombosis. / R.C. Starling [et al.] // N Engl J Med. – 2014. – Vol. 370(1). – P. 33-40.
Conservative approaches for HeartWare ventricular assist device pump thrombosis may improve the outcome compared with immediate surgical approaches. / D. Saeed [et al.] // Interact Cardiovasc Thorac Surg. – 2016. – Vol. 23(1). – P. 90-95.
Readmissions After Continuous Flow Left Ventricular Assist Device Implantation: Differences Observed Between Two Contemporary Device Types. / N.A. Haglund [et al.] // ASAIO J. – 2015. – Vol. 61(4). – P. 410-416.
Infectious complications in patients with left ventricular assist device: etiology and outcomes in the continuous-flow era. / V.K. Topkara [et al.] // Ann Thorac Surg. – 2010. – Vol. 90(4). – P. 1270-1277.
Leuck, A.M. Left ventricular assist device driveline infections: recent advances and future goals. / A.M. Leuck [et al.] // J Thorac Dis. – 2015. – Vol. 7(12). – P. 2151-2157.
Left ventricular assist device exchange for persistent infection: a case series and review of the literature. / D.T. Levy [et al.] // Transpl Infect Dis. – 2014. – Vol. 16(3). – P. 453-460.
Effect of left ventricular assist device infection on post-transplant outcomes. / A.R. Schulman [et al.] // J Heart Lung Transplant. – 2009. – Vol. 28(3). – P. 237-242.
Salvage of infected left ventricular assist device with antibiotic beads. / J.D. Kretlow [et al.] // Plast Reconstr Surg. – 2014. – Vol. 133(1). – P. 28e-38e.
De novo aortic insufficiency during long-term support on a left ventricular assist device: a systematic review and meta-analysis. / S.V. Deo [et al.] // ASAIO J. – 2014. – Vol. 60(2). – P. 183-188.
Prevalence of De Novo Aortic Valve Insufficiency in Patients After HeartWare VAD Implantation with an Intermittent Low-Speed Algorithm. / D. Saeed [et al.] // ASAIO J. – 2016. – Vol. 62(5). – P. 565-570.
Assessment and management of right ventricular failure in left ventricular assist device patients. / W.L. Holman [et al.] // Circ J. – 2015. – Vol. 79(3). – P. 478-86.
Left Ventricular Assist Devices and the Kidney. / R.W. Daniel [et al.] // Clin J Am Soc Nephrol. – 2018. – Vol. 13. – P. 348–355.
Roehm, B., Vest, A. R., Weiner, D.E. Left Ventricular Assist Devices, Kidney Disease, and Dialysis. / B. Roehm, A.R. Vest, D.E. Weiner // Am J Kidney Dis. – 2017. – Vol. 71(2). – P. 257-266.
